PRENYLAMINE IN ANGINA PECTORIS
- 1 January 1963
- journal article
- research article
- Vol. 89 (6) , 248-+
Abstract
The therapeutic value of prenylamine in angina pectoris was tested in 2 ways. Fourteen patients received 270 mg of prenylamine/day for 1 month. This was preceded and followed by 1 month of placebo therapy. Assessment was made, first by twice-monthly treadmill exercise tests, and secondly by daily records of anginal attacks and nitroglycerin usage. The occurrence of pain and ecg changes during treadmill exercise was apparently uninfluenced by the drug. However, there was a reduced incidence of spontaneous angina and nitroglycerin usage during the month on prenylamine by contrast with either month on placebo (p< 0.05).Keywords
This publication has 10 references indexed in Scilit:
- Studies with a new coronary vasodilator drug: PersantinAmerican Heart Journal, 1962
- [Circulatory observations in the treatment of coronary insufficiency].1961
- [Electrocardiographic research and clinical observations on the action of Segontin in the angina pectoris syndrome].1961
- [On the therapy of coronary insufficiency as a secondary finding].1960
- [On new possibilities in the therapy of coronary circulation disorders].1960
- [Clinical experiences with segontin].1960
- [A double-blind experiment with the coronary therapeutic agent segontin].1960
- [Clinical studies on monoamine metabolism under the influence of segontin].1960
- [N-(3-phenylisopropyl)-3,3-diphenylpropylamine, a new substance with a dilating action on the coronary vessels. Part 1: Action on the circulation].1960
- THE EFFORT TEST IN ANGINA PECTORISHeart, 1950